| Article ID | Journal | Published Year | Pages | File Type |
|---|---|---|---|---|
| 5888217 | Experimental and Molecular Pathology | 2013 | 12 Pages |
Abstract
⺠The role of RGC-32 in multiple sclerosis was investigated. ⺠RGC-32 was found to be present in multiple sclerosis brain tissue. ⺠RGC-32 was found to be a biomarker for relapses in multiple sclerosis. ⺠RGC-32 regulates FasL expression by CD4 positive cells. ⺠RGC-32 mediates TGF-β-induced extracellular matrix expression in astrocytes.
Related Topics
Life Sciences
Biochemistry, Genetics and Molecular Biology
Clinical Biochemistry
Authors
Cosmin A. Tegla, Cornelia D. Cudrici, Philippe Azimzadeh, Anil K. Singh, Richard III, Ali Khan, Hegang Chen, Maria Andrian-Albescu, Walter III, Christopher Bever, Violeta Rus, Horea Rus,